Faculty of Pharmaceutical Sciences

Activities

Activities per year 1990 2011 2012 2013 2014 2015 2016 2017 2018 2025

• 2140 Oral presentation
• 78 social activities
• 52 Academic activities
• 18 Invited talk
• 12 More
  • 5 Other reseach activity
  • 5 Other educational activity
  • 1 Participating in a conference, workshop
  • 1 Editorial work

Activities per year

Search results

• 非常勤講師

  Nitta, A. (Participant)

  2014/09 → 2017/03

  Activity: Other › social activities

• Secretory CTGF mediates autonomous MET-like alterations in mesenchymal-transitioned A549 cells.

  Yokoyama, S. (Speaker)

  2014/09

  Activity: Talk or presentation › Oral presentation

• Piperine enhances the efficacy of trail-based therapy for triple-negative breast cancer cells.

  Yokoyama, S. (Speaker)

  2014/09

  Activity: Talk or presentation › Oral presentation

• メラノーマの転移抑制を目指したSLUGに対する脱ユビキチン化酵素の探索

  Yokoyama, S. (Speaker)

  2014/09

  Activity: Talk or presentation › Oral presentation

• 東北哲学会 (External organization)

  Miyajima, M. (Member)

  2014/09 → …

  Activity: Membership › Academic activities

• 腎がん・肺がんの転移抑制活性を有する生薬の探索とその機序解析

  Yokoyama, S. (Speaker)

  2014/09

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンによる糖代謝リズム調節を介したインスリン抵抗性の治療戦略．

  Tsuneki, H. (Speaker)

  2014/08/28 → 2014/08/29

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンによる糖代謝リズム調節を介したインスリン抵抗性の治療戦略．

  Wada, T. (Speaker)

  2014/08/28 → 2014/08/29

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンによる糖代謝リズム調節を介したインスリン抵抗性の治療戦略．

  Sasaoka, T. (Speaker)

  2014/08/28 → 2014/08/29

  Activity: Talk or presentation › Oral presentation

• 光アフィニティーラベル法による複数リガンドの結合解析

  Chiba, J. (Speaker)

  2014/08/20 → 2014/08/21

  Activity: Talk or presentation › Oral presentation

• Fluoro azetidines and difluoro prolines from D-glucose; Inhibition of pancreatic cancer cell growth by a fluoro azetidine

  Kato, A. (Speaker)

  2014/08/10 → 2014/08/14

  Activity: Talk or presentation › Oral presentation

• Sensitization for anti-cancer drug by Saikosaponin B2

  Yokoyama, S. (Speaker)

  2014/08

  Activity: Talk or presentation › Oral presentation

• Identification of novel anti-inflammatory compounds from Morus alba Linne by targeting NF-kB

  Yokoyama, S. (Speaker)

  2014/08

  Activity: Talk or presentation › Oral presentation

• 漢方シグナルパネルの構築とその応用

  Yokoyama, S. (Speaker)

  2014/08

  Activity: Talk or presentation › Oral presentation

• 光アフィニティー蛍光ラベル法による構造情報に基づいた結合解析

  Chiba, J. (Speaker)

  2014/07/25 → 2014/07/26

  Activity: Talk or presentation › Oral presentation

• 肝特異的SREBP1c過剰発現マウスを用いたNASHモデルマウスに対する，鉱質コルチコイド受容体阻害剤のNASH病態制御機構．

  Sasaoka, T. (Speaker)

  2014/07/04

  Activity: Talk or presentation › Oral presentation

• 肝特異的SREBP1c過剰発現マウスを用いたNASHモデルマウスに対する，鉱質コルチコイド受容体阻害剤のNASH病態制御機構．

  Wada, T. (Speaker)

  2014/07/04

  Activity: Talk or presentation › Oral presentation

• 肝特異的SREBP1c過剰発現マウスを用いたNASHモデルマウスに対する，鉱質コルチコイド受容体阻害剤のNASH病態制御機構．

  Tsuneki, H. (Speaker)

  2014/07/04

  Activity: Talk or presentation › Oral presentation

• Action of Chemokine (C-C motif) ligand 1 on synaptic transmission in the spinal superficial dorsal horn.

  Uta, D. (Speaker)

  2014/07/01 → 2014/07/02

  Activity: Talk or presentation › Oral presentation

• 肺がんにおけるSNAILに対する脱ユビキチン化酵素の探索

  Yokoyama, S. (Speaker)

  2014/07

  Activity: Talk or presentation › Oral presentation

• 細胞内シグナルからみる天然薬物

  Yokoyama, S. (Speaker)

  2014/07

  Activity: Talk or presentation › Oral presentation

• メタンフェミタンの連続投与は精神疾患関連遺伝子Shati/Nat8lのDNAメチル化の割合を低下させる

  Nitta, A. (Speaker)

  2014/06/28 → 2014/06/29

  Activity: Talk or presentation › Oral presentation

• 薬剤師-患者間のコミュニュケーションに関する研究　第２報：構築したコミュニュケーション学習プログラムの検証

  Nitta, A. (Speaker)

  2014/06/28 → 2014/06/29

  Activity: Talk or presentation › Oral presentation

• Effects of pseudoginsenoside-F11 on methamphetamine-induced behaviors related to the dopaminergic and GABAergic neuronal system in the nucleus accumbens

  Nitta, A. (Speaker)

  2014/06/22 → 2014/06/26

  Activity: Talk or presentation › Oral presentation

• PCLO SNP rs13438494 regulates DA and 5-HT uptake, accompanied with splicing efficiency and dependence-like behaviors in genomic association studies

  Nitta, A. (Speaker)

  2014/06/22 → 2014/06/26

  Activity: Talk or presentation › Oral presentation

• Depression-like behaviors were induced by overexpression of Shati/Nat8l, an N-acetyltransferase, in the striatum of mice.

  Nitta, A. (Speaker)

  2014/06/22 → 2014/06/26

  Activity: Talk or presentation › Oral presentation

• A pain-enhancing mechanism involving the interaction between TRPV1 and anoctamin 1.

  Uta, D. (Speaker)

  2014/06/20 → 2014/06/21

  Activity: Talk or presentation › Oral presentation

• Effect of TRPA1 and TRPV1 agonists on synaptic transmission evoked in morphologically distinct cell types in the substantia gelatinosa of the adult rat spinal cord.

  Uta, D. (Speaker)

  2014/06/20 → 2014/06/21

  Activity: Talk or presentation › Oral presentation

• Action of CCL-1 on synaptic transmission in the spinal dorsal horn.

  Uta, D. (Speaker)

  2014/06/20 → 2014/06/21

  Activity: Talk or presentation › Oral presentation

• Inhibition of PDGF receptor improves insulin resistance by suppression of chronic inflammation via reduction of MCP1 expression in the adipose tissue of type 2 diabetes mice.

  Sasaoka, T. (Speaker)

  2014/06/13 → 2014/06/17

  Activity: Talk or presentation › Oral presentation

• Hypothalamic orexin prevents hepatic insulin resistance via bidirectional regulation of autonomic nervous system in mice.

  Sasaoka, T. (Speaker)

  2014/06/13 → 2014/06/17

  Activity: Talk or presentation › Oral presentation

• Inhibition of PDGF receptor improves insulin resistance by suppression of chronic inflammation via reduction of MCP1 expression in the adipose tissue of type 2 diabetes mice.

  Tsuneki, H. (Speaker)

  2014/06/13 → 2014/06/17

  Activity: Talk or presentation › Oral presentation

• Hypothalamic orexin prevents hepatic insulin resistance via bidirectional regulation of autonomic nervous system in mice.

  Wada, T. (Speaker)

  2014/06/13 → 2014/06/17

  Activity: Talk or presentation › Oral presentation

• Hypothalamic orexin prevents hepatic insulin resistance via bidirectional regulation of autonomic nervous system in mice.

  Tsuneki, H. (Speaker)

  2014/06/13 → 2014/06/17

  Activity: Talk or presentation › Oral presentation

• Inhibition of PDGF receptor improves insulin resistance by suppression of chronic inflammation via reduction of MCP1 expression in the adipose tissue of type 2 diabetes mice.

  Wada, T. (Speaker)

  2014/06/13 → 2014/06/17

  Activity: Talk or presentation › Oral presentation

• Functional characterization of an inducible NADPH:cytochrome P450 reductase from a tropical medicinal plant #IScoparia dulcis#IR.

  Yamamura, Y. (Speaker)

  2014/06/12 → 2014/06/16

  Activity: Talk or presentation › Oral presentation

• 高性能光アフィニティーラベリングのプロテオミクスへの展開

  Chiba, J. (Speaker)

  2014/06/11 → 2014/06/13

  Activity: Talk or presentation › Oral presentation

• フェロセン修飾 DNA の電荷移動速度定数を指標とした 光損傷 DNA 二重鎖の柔軟性評価

  Chiba, J. (Speaker)

  2014/06/11 → 2014/06/13

  Activity: Talk or presentation › Oral presentation

• 東海支部 特別講演会

  Nitta, A. (Participant)

  2014/06

  Activity: Other › social activities

• 日本神経化学会 (External organization)

  Nitta, A. (Member)

  2014/06 → 2017/10

  Activity: Membership › Academic activities

• Synthesis and Characterization of Germa[n]pericyclynes

  Tanimoto, H. (Speaker)

  2014/05/31

  Activity: Talk or presentation › Oral presentation

• Molecular mechanism of anti-inflammatory actions of eplerenone in macrophage.

  Sasaoka, T. (Speaker)

  2014/05/31

  Activity: Talk or presentation › Oral presentation

• Molecular mechanism of anti-inflammatory actions of eplerenone in macrophage.

  Wada, T. (Speaker)

  2014/05/31

  Activity: Talk or presentation › Oral presentation

• 小児の同種造血幹細胞移植患者におけるタクロリムスの血中濃度モニタリングとバイオアベイラビリティの個体内変動

  Taguchi, M. (Speaker)

  2014/05/31 → 2014/06/01

  Activity: Talk or presentation › Oral presentation

• Molecular mechanism of anti-inflammatory actions of eplerenone in macrophage.

  Tsuneki, H. (Speaker)

  2014/05/31

  Activity: Talk or presentation › Oral presentation

• A nitro sugar based route to branched-chain polyhydroxylated octahydro-1H-indole-4,5,6-triols, as new potential glycosides inhibitors.

  Kato, A. (Speaker)

  2014/05/28 → 2014/05/30

  Activity: Talk or presentation › Oral presentation

• 視床下部オレキシンによるマウス肝糖新生の概日リズムの調節機構の解析．

  Sasaoka, T. (Speaker)

  2014/05/22 → 2014/05/24

  Activity: Talk or presentation › Oral presentation

• 選択的Mineralocorticoid Receptor (MR) 阻害剤による抗炎症作用の分子メカニズムの解明．

  Sasaoka, T. (Speaker)

  2014/05/22 → 2014/05/24

  Activity: Talk or presentation › Oral presentation

• 選択的Mineralocorticoid Receptor (MR) 阻害剤による抗炎症作用の分子メカニズムの解明．

  Tsuneki, H. (Speaker)

  2014/05/22 → 2014/05/24

  Activity: Talk or presentation › Oral presentation

• アンジオテンシンⅡによる培養血管内皮細胞のインスリン抵抗性に対するコエンザムQ10の改善効果．

  Tsuneki, H. (Speaker)

  2014/05/22 → 2014/05/24

  Activity: Talk or presentation › Oral presentation